Frequency Therapeutics Inc. FREQ stock imploded Tuesday amid the company's announcement that its interim FX-322 Phase 2a results showed that four weekly injections did not demonstrate improvements in hearing measures versus a placebo.
The stock was down 76.81% at $8.42 at last check. 
Frequency Therapeutics Short-Term Chart Analysis: The 5-minute chart above shows the stock immediately started dropping after the announcement.
The stock was able to find a bottom at the $8.75 mark. This area is a place where a trader could find support in the future.
In the short term, the stock may find resistance near the $14 level. This area is speculatively based on an area where the stock previously attempted to bounce, but was unable to do so.
The stock is trading below both the 200-day moving average (blue) and the volume-weighted average price (pink). This gives the stock short term bearish sentiment.
The stock may find short-term resistance near these indicators.
Frequency Therapeutics Daily Chart Analysis: The daily chart above shows the stock was trading with $30 as support before the implosion. This area may be a resistance in the future if the stock is able to make it back to this level.
Long-term speculative support comes at the same area as short-term support, near $8.75. This is the only area traders have seen a bounce so far in the chart.
The stock trades below the 200-day moving average, indicating long-term bearish sentiment. The stock may find resistance near this indicator.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
